LUNAR Trial Update: ¹⁷⁷Lu-PNT2002 Before SBRT in Oligorecurrent Prostate Cancer
Beyond MSI Status: A New Biomarker of Immunotherapy Resistance in Colorectal Cancer
Zainab Shinkafi-Bagudu Outlines Priorities for the Future of Global Cancer Control - UICC
Pelé’s Cause of Death: Brazilian Football King’s Battle With Colon Cancer
CT, MRI, and PET/CT in Cancer Diagnosis: Key Differences
Neoadjuvant vs Definitive ChemoRT in cN3M0 Esophageal Cancer: A Nationwide Dutch Study
City of Hope Receives $11 Million Gift to Advance Personalized Cancer Care
Enrique Grande: New Review Highlights Major Advances in Perioperative Treatment for Bladder Cancer
The 2026 Accelerating Anticancer Agent Development and Validation (AAADV) Workshop will take place on November 5–6, 2026, at the Bethesda North Marriott Hotel & Conference Center in Maryland, with both […]
